Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

B7438

Sigma-Aldrich

6-B345TTQ

>98% (HPLC)

Synonym(s):

6-Bromo-3,4-dihydro-4-(3,4,5-trimethoxyphenyl)-benzo[h]quinolin-2(1H)-one

Sign Into View Organizational & Contract Pricing

Select a Size

5 MG
¥23,140
25 MG
¥71,330

¥23,140


Estimated to ship onApril 14, 2025



Select a Size

Change View
5 MG
¥23,140
25 MG
¥71,330

About This Item

Empirical Formula (Hill Notation):
C22H20BrNO4
CAS Number:
Molecular Weight:
442.30
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77

¥23,140


Estimated to ship onApril 14, 2025


Quality Level

Assay

>98% (HPLC)

form

powder

color

white to off-white

solubility

DMSO: ≥20 mg/mL

storage temp.

2-8°C

SMILES string

COc1cc(cc(OC)c1OC)C2CC(=O)Nc3c2cc(Br)c4ccccc34

InChI

1S/C22H20BrNO4/c1-26-18-8-12(9-19(27-2)22(18)28-3)15-11-20(25)24-21-14-7-5-4-6-13(14)17(23)10-16(15)21/h4-10,15H,11H2,1-3H3,(H,24,25)

InChI key

KPOXOTVERMGJQS-UHFFFAOYSA-N

Biochem/physiol Actions

6-B345TTQ is a non-cytotoxic inhibitor of α4 integrin paxillin interaction.

Pictograms

Environment

Signal Word

Warning

Hazard Statements

Precautionary Statements

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

B7438-5MG:
B7438-BULK:
B7438-25MG:
B7438-VAR:


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jordan J Toutounchian et al.
Molecular pharmacology, 91(1), 1-13 (2016-12-04)
Targeting vascular endothelial growth factor (VEGF) is a common treatment strategy for neovascular eye disease, a major cause of vision loss in diabetic retinopathy and age-related macular degeneration. However, the decline in clinical efficacy over time in many patients suggests
Daniela Alfano et al.
Human molecular genetics, 28(14), 2295-2308 (2019-06-11)
Tbx1, the major candidate gene for DiGeorge or 22q11.2 deletion syndrome, is required for efficient incorporation of cardiac progenitors of the second heart field (SHF) into the heart. However, the mechanisms by which TBX1 regulates this process are still unclear.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service